Keith Norris to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications Keith Norris has written about Diabetes Mellitus, Type 2.
Connection Strength
2.263
-
Nee R, Yuan CM, Narva AS, Yan G, Norris KC. Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease. Nephrol Dial Transplant. 2023 02 28; 38(3):532-541.
Score: 0.512
-
Shen JI, Nicholas SB, Williams S, Norris KC. Evidence for and Against ACC/AHA 2017 Guideline for Target Systolic Blood Pressure of
View in: PubMed
Score: 0.409
Norris KC, Smoyer KE, Rolland C, Van der Vaart J, Grubb EB. Albuminuria, serum creatinine, and estimated glomerular filtration rate as predictors of cardio-renal outcomes in patients with type 2 diabetes mellitus and kidney disease: a systematic literature review. BMC Nephrol. 2018 02 09; 19(1):36.
Score: 0.361
Nicholas SB, Daratha KB, Alicic RZ, Jones CR, Kornowske LM, Neumiller JJ, Fatoba ST, Kong SX, Singh R, Norris KC, Tuttle KR. Prescription of guideline-directed medical therapies in patients with diabetes and chronic kidney disease from the CURE-CKD Registry, 2019-2020. Diabetes Obes Metab. 2023 10; 25(10):2970-2979.
Score: 0.131
Chang TI, Li S, Chen SC, Peralta CA, Shlipak MG, Fried LF, Whaley-Connell AT, McCullough PA, Kurella Tamura M. Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2013 04; 61(4 Suppl 2):S4-11.
Score: 0.129
Vu A, Nicholas SB, Waterman AD, Madievsky R, Cheng F, Chon J, Fu JY, Mangione CM, Norris KC, Duru OK. "Positive Kidney Health": Implementation and design of a pharmacist-led intervention for patients at risk for development or progression of chronic kidney disease. J Am Pharm Assoc (2003). 2023 Mar-Apr; 63(2):681-689.
Score: 0.126
Madievsky R, Vu A, Cheng F, Chon J, Turk N, Krueger A, Krong J, Maranon R, Liu S, Han CS, Norris KC, Mangione C, Page J, Thomas S, Duru OK, Moin T. A randomized controlled trial of a shared decision making intervention for diabetes prevention for women with a history of gestational diabetes mellitus: The Gestational diabetes Risk Attenuation for New Diabetes (GRAND study). Contemp Clin Trials. 2023 01; 124:107007.
Score: 0.126
Tuttle KR, Jones CR, Daratha KB, Koyama AK, Nicholas SB, Alicic RZ, Duru OK, Neumiller JJ, Norris KC, R?os Burrows N, Pavkov ME. Incidence of Chronic Kidney Disease among Adults with Diabetes, 2015-2020. N Engl J Med. 2022 10 13; 387(15):1430-1431.
Score: 0.125
Moin T, Martin JM, Mangione CM, Grotts J, Turk N, Norris KC, Tseng CH, Jeffers KS, Castellon-Lopez Y, Frosch DL, Duru OK. Choice of Intensive Lifestyle Change and/or Metformin after Shared Decision Making for Diabetes Prevention: Results from the Prediabetes Informed Decisions and Education (PRIDE) Study. Med Decis Making. 2021 07; 41(5):607-613.
Score: 0.112
Sinha SK, Nicholas SB, Sung JH, Correa A, Rajavashisth TB, Norris KC, Lee JE. hs-CRP Is Associated With Incident Diabetic Nephropathy: Findings From the Jackson Heart Study. Diabetes Care. 2019 11; 42(11):2083-2089.
Score: 0.101
Bobart SA, Gleason B, Martinez N, Norris K, Williams SF. Euglycemic Ketoacidosis Caused by Sodium-Glucose Cotransporter 2 Inhibitors: A Case Report. Ann Intern Med. 2016 Oct 04; 165(7):530-532.
Score: 0.082
Pradhan R, Fong D, March C, Jack R, Rezapour G, Norris K, Davidson MB. Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive Type 2 diabetic patients. A pilot study. J Diabetes Complications. 2002 Nov-Dec; 16(6):377-81.
Score: 0.031
Agodoa L, Norris K, Pugsley D. The disproportionate burden of kidney disease in those who can least afford it. Kidney Int Suppl. 2005 Aug; (97):S1-3.
Score: 0.009
Mehrotra R, Budoff M, Christenson P, Ipp E, Takasu J, Gupta A, Norris K, Adler S. Determinants of coronary artery calcification in diabetics with and without nephropathy. Kidney Int. 2004 Nov; 66(5):2022-31.
Score: 0.009